For individuals living with sickle cell disease (SCD), the transition from pediatric to adult care can be one of the most ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...

Porscha Burks lives a normal life in many ways. She is the mother to an 8-year-old boy and works as a patient service representative at a North Side clinic. However, there is one thing that sets her ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

June 19 is marked as World Sickle Cell Awareness Day, granting the opportunity to reflect on the current state of treatment, access, equity, and more that impacts patients living with sickle cell ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

Five studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition reveal new ...

Specialist Haematologist Dr. Ansah-Otu Williams has debunked and clarified several myths and misconceptions surrounding sickle cell disease.

Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies90% (9 of 10) of patients ...